Skip to content

BGM Group Ltd.

BGM

CIK 0001779578 · Pharmaceutical Preparations · Nasdaq

  • Qilian International Holding Group (until 2024-10-22)
  • Qilian International Holding Group Ltd (until 2024-10-16)
← back to feed
Revenue (TTM)
$25.1M
−46.0% YoY Q2 Mar 2025
Net Income (TTM)
−$1.44M
+81.5% YoY Q2 Mar 2025
EPS Diluted (TTM)
−$0.20
+81.5% YoY Q2 Mar 2025
Gross Margin
16.4%
Q2 Mar 2025
Operating Margin
-2.2%
Q2 Mar 2025
Net Margin
-5.7%
Q2 Mar 2025
Free Cash Flow (TTM)
$304.11K
Q2 Mar 2025
Cash
$9.65M
Q2 Mar 2025
Total Debt
—
Q2 Mar 2025
Shares Outstanding
35.75M sh
Q2 Mar 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings